Supply of Magistral Compounding Medications

This tender seeks the supply of medications for magistral compounding. Magistral compounding refers to the preparation of customized medications by a pharmacist based on a physician's prescription for an individual patient. This process allows for tailored dosages, formulations, or combinations of active ingredients that are not available as commercially manufactured drugs. The tender is likely aimed at healthcare institutions, pharmacies, or research facilities that require a consistent and reliable source of raw materials or pre-compounded components for preparing these personalized medications. The scope of supply may include a range of active pharmaceutical ingredients (APIs), excipients, and potentially semi-finished preparations. Key requirements will likely focus on the quality, purity, and traceability of the supplied substances, adherence to Good Manufacturing Practices (GMP) or equivalent standards, and timely delivery. The contract will specify the types and quantities of medications or components to be supplied, along with detailed quality control and documentation requirements. Bidders must demonstrate their capability to meet stringent pharmaceutical standards and provide a secure supply chain for these specialized medicinal products.

This is a supplies contract in the health and medical services, trade and industry and Research sectors, with a focus on Pharmaceuticals and Manufacturing. Located in Chile, Latin America, this opportunity is open to firms and consortiums.

Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.